CytoMed Executive Chairman and substantial shareholder, Peter Choo has increased his shareholding in the Company through recent open-market purchases of 105,824 shares. This is on top of 187,500 shares which he holds personally, bringing his personal stake in CytoMed to 2.50% as of today. In addition, our Chairman is also a 55% shareholder of Glorious Finance Limited, and the sole shareholder of EP Capital Inc, representing 2,282,422 shares, or 19.45% of the Company. In aggregate, he owns 2,388,246 shares representing 21.95% of the Company’s total outstanding shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDTC:
- CytoMed Therapeutics Bids for TC BioPharm’s Assets Amid Strategic Expansion
- Cytomed announces cash bid for potential acquisition of TC BioPharm
- CytoMed Therapeutics Unveils Promising AML Therapy Research
- Cytomed Therapeutics announces publication of research on T cells
- CytoMed Therapeutics Reports Increased Revenue Amidst Financial Challenges